| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |